Ex Vivo Gene Therapy Program

September 1, 2017

pHion is proud to announce a collaboration with Cell and Gene Therapy Catapult UK.  The goal of this collaboration is to apply RALA to Ex Vivo gene therapy applications and replace viral delivery for applications such as Car-T and stem cell based gene therapies.  The determining factor to choose pHion and RALA for this program was the unmatched cell transfection efficiency with low associated cellular toxicity.

Share on Facebook
Share on Twitter
Please reload

© 2019 by pHion Therapeutics Ltd.

  • Twitter - White Circle
  • Facebook - White Circle
  • LinkedIn - White Circle

pHion Therapeutics Ltd.

School of Pharmacy

Medical Biology Centre

97 Lisburn Road 



United Kingdom